Abstract P5-07-16: How cardiovascular risk factors and type of chemotherapy influence cardiotoxicity in early HER2 positive breast cancer (HER2+ BC) patients treated with neoadjuvant Trastuzumab and Pertuzumab (T-P) based chemotherapy? | Publicación